Yu Zhen, Xun Wenxing, Ren Pan, Ma Fuxin, Bian Yongqian, Zhao Congying, Li Jinqing
The Plastic and Reconstructive Surgery Department of Xi'an People's Hospital, Xi'an Fourth Hospital, Xi'an, 710038, China.
Department of Burn and Plastic Surgery, Tangdu Hospital, Air Force Medical University, Xi'an, 710038, China.
World J Surg Oncol. 2025 May 23;23(1):201. doi: 10.1186/s12957-025-03862-7.
The purpose of our study was to evaluate the clinical effect of a facelift combined with a modified overlapping superficial musculoaponeurotic system (SMAS) flap for repairing facial depression caused by the resection of benign parotid lesions.
This retrospective, non-randomized observational study included 87 patients diagnosed with benign parotid tumors who underwent surgical treatment between June 2014 and September 2023. All patients were treated in our department or by the same surgical team after institutional transfer. All patients received surgery via a standardized facelift incision approach.; All patients underwent surgery using a standardized facelift incision. Of them, 58 patients received reconstructive surgery with the modified SMAS flap, and 29 patients were treated using the classical SMAS flap. The degree of satisfaction with scarring and facial depression was assessed 6 months postoperatively using the Vancouver Scar Scale (VSS) and a 10-point scale (0 = no obvious depression; 10 = severe depression), respectively.
There was no significant difference regarding the degree of satisfaction with scarring between the two groups (P > 0.05), while the modified SMAS flap group was significantly more satisfied with the facial depressions than the classical SMAS flap group (P < 0.001). Surgical complications and tumor recurrence were not significantly different between the two groups.
A facelift combined with a modified SMAS flap can effectively repair the facial depressions caused by the resection of benign parotid lesions and achieve good aesthetic results.
本研究旨在评估面部提升术联合改良重叠浅表肌肉腱膜系统(SMAS)皮瓣修复腮腺良性病变切除术后面部凹陷的临床效果。
这项回顾性、非随机观察性研究纳入了2014年6月至2023年9月期间接受手术治疗的87例诊断为腮腺良性肿瘤的患者。所有患者均在我院或机构转诊后由同一手术团队进行治疗。所有患者均通过标准化的面部提升切口入路接受手术;所有患者均采用标准化的面部提升切口进行手术。其中,58例患者采用改良SMAS皮瓣进行重建手术,29例患者采用经典SMAS皮瓣进行治疗。术后6个月分别使用温哥华瘢痕量表(VSS)和10分制量表(0=无明显凹陷;10=严重凹陷)评估对瘢痕和面部凹陷的满意度。
两组之间对瘢痕的满意度程度无显著差异(P>0.05),而改良SMAS皮瓣组对面部凹陷的满意度明显高于经典SMAS皮瓣组(P<0.001)。两组之间的手术并发症和肿瘤复发情况无显著差异。
面部提升术联合改良SMAS皮瓣可有效修复腮腺良性病变切除术后的面部凹陷,并取得良好的美学效果。